Does Chlamydia trachomatis MoPn enter a microbiologically-inapparent state during experimental infection of the mouse genital tract?

Microbial Pathogenesis

Volumn 22, Issue 2, 1997, Pages 99-112

  Beale, Angela S ^a,b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b NONE   (United Kingdom)

Author keywords

C. trachomatis; experimental salpingitis; IFN ; immunosuppression; non cultivability; PCR

Indexed keywords

GAMMA INTERFERON;

ANIMAL EXPERIMENT; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; FEMALE; GENITAL TRACT INFECTION; IMMUNOSUPPRESSIVE TREATMENT; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SALPINGITIS;

EID: 0031080288     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1996.0096     Document Type: Article

References (54)

1. 1 Oehme A, Musholt PB, Dreesbach K. Chlamydiae as pathogens - an overview of diagnostic techniques, clinical features, and therapy of human infections. Klin Wochenschr 1991; 69: 463-73.
2. 2 Schachter J, Storz J, Tarizzo ML, Bogel K. Chlamydia as agents of human and animal disease. Bull WHO 1973; 49: 443-9.
3. 3 Morrison RP, Manning DS, Caldwell HD. Immunology of Chlamydia trachomatis infections: immunoprotective and immunopathogenic responses. In: Quinn TC, ed. Sexually transmitted diseases. New York: Raven Press Ltd, 1992: 57-84.
4. 4 Brunham RC, Maclean IW, Binns B, Peeling RW. Chlamydia trachomatis: its role in tubal infertility. J Infect Dis 1985; 152: 1275-82.
5. 5 Morrison RP, Belland RJ, Lyng K, Caldwell HD. Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein. J Exp Med 1989; 170: 1271-83.
6. 6 Patton DL, Sweeney YTC, Kuo C-C. Demonstration of delayed hypersensitivity in Chlamydia trachomatis salpingitis in monkeys: a pathogenic mechanism of tubal damage. J Infect Dis 1994; 169: 680-3.
7. 7 Witkin SS, Jeremias J, Toth M, Ledger WJ. Proliferative response to conserved epitopes of the Chlamydia trachomatis and human 60-kilodalton heat-shock proteins by lymphocytes from women with salpingitis. Amer J Obstet Gynecol 1994; 171: 455-60.
8. 8 Grayston JT, Wang SP, Yeh LJ, Kuo CC. Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis 1985; 7: 717-25.
9. 9 Beatty WL, Byrne GI, Morrison RP. Morphologic and antigenic characterization of interferon γ-mediated persistent Chlamydia trachomatis infection in vitro. Proc Nat Acad Sci 1993; 90: 3998-4002.
10. 10 Beatty WL, Morrison RP, Byrne GI. Reactivation of persistent Chlamydia trachomatis infection in cell culture. Infect Immun 1995; 63: 199-205.
11. 11 Coles AM, Reynolds DJ, Harper A, Devitt A, Pearce JH. Low-nutrient induction of abnormal chlamydial development: a novel component of chlamydial pathogenesis? FEMS Microbiol Lett 1993; 106: 193-200.
12. 12 Shemer Y, Sarov I. Inhibition of growth of Chlamydia trachomatis by human gamma interferon. Infect Immun 1985; 48: 592-6.
13. 13 Beatty WL, Belanger TA, Desai AA, Morrison RP, Byrne GI. Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence. Infect Immun 1994; 62: 3705-11.
14. 14 Cappuccio AL, Patton DL, Kuo C-C, Campbell LA. Detection of Chlamydia trachomatis deoxyribonucleic acid in monkey models (Macaca nemestrina) of salpingitis by in situ hybridization: implications for pathogenesis. Am J Obstet Gynecol 1994; 171: 102-10.
15. 15 Ozanne G, Pearce JH. Inapparent chlamydial infection in the urogenital tract of guinea pigs. J Gen Microbiol 1980; 119: 351-9.
16. 16 Pasley JN, White HJ, Barron AL. Persistent chronic active cervicitis: a newly noted finding in an animal model of chlamydial genital disease. J Infect Dis 1990; 162: 1219-20.
17. 17 Campbell LA, Patton DL, Moore DE, Cappuccio AL, Mueller BA, Wang S-P. Detection of Chlamydia trachomatis deoxyribonucleic acid in women with tubal infertility. Fertil Steril 1993; 59: 45-50.
18. 18 Nanagara R, Li F, Beutler A, Hudson A, Schumacher HR. Alteration of Chlamydia trachomatis biologic behaviour in synovial membranes. Arthr Rheum 1995; 38: 1410-7.
19. 19 Schachter J, Moncada J, Dawson CR, Sheppard J, Courtright P, Said ME, Zaki S, Hafez SF, Lorincz A. Non-culture methods for diagnosing chlamydial infection in patients with trachoma: a clue to the pathogenesis of the disease? J Infect Dis 1988; 158: 1347-52.
20. 20 Beale AS, Upshon PA. Characteristics of murine model of genital infection with Chlamydia trachomatis and effects of therapy with tetracyclines, amoxicillin-clavulanic acid or azithromycin. Antimicrob Agents Chemother 1994; 38: 1937-43.
21. 21 de la Maza LM, Pal S, Khamesipour A, Peterson EM. Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect Immun 1994; 62: 2094-7.
22. 22 Nigg C. An unidentified virus which produces pneumonia and systemic infection in mice. Science 1942; 95: 49-50.
23. 23 Pal S, Fielder TJ, Peterson EM, de la Maza LM. Analysis of the immune response in mice following intrauterine infection with the Chlamydia trachomatis mouse pneumonitis biovar. Infect Immun 1993; 61: 772-6.
24. 24 Pal S, Fielder TJ, Peterson EM, de la Maza LM. Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect Immunol 1994; 62: 3354-62.
25. 25 Cotter T, Meng Q, Shen Z, Zhang Y, Su H, Caldwell HD. Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect Immun 1995; 63: 4704-14.
26. 26 Morrison RP, Feilzer K, Tumas DB. Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection. Infect Immun 1995; 63: 4661-8.
27. 27 Palmer L, Falkow S. A common plasmid of Chlamydia trachomatis. Plasmid 1986; 16: 52-62.
28. 28 Mahoney JB, Luinstra KE, Sellers JW, Chernesky MA. Comparison of plasmid- and chromosome-based polymerase chain reaction assays for detecting Chlamydia trachomatis nucleic acids. J Clin Microbiol 1993; 31:1753-8.
29. 29 Roosendaal R, Walboomers JMM, Veltman OR, Melgers I, Burger C, Bleker OP, MacLaren DM, Meijer CJLM, van den Brule AJC. Comparison of different primer sets for detection of Chlamydia trachomatis by the polymerase chain reaction. J Med Microbiol 1993; 38: 426-33.
30. 30 Martin JL, Alexander SY, Selwood TS, Cross GF. Use of the polymerase chain reaction for the detection of Chlamydia trachomatis in clinical specimens and its comparison to commercially available tests. Genitourin Med 1995; 71: 169-71.
31. 31 Karch H, Schwarzkopf A, Schmidt H. Amplification methods in diagnosis bacteriology (selected examples). J Microbiol Methods 1995; 23: 55-73.
32. 32 Kowalski RP, Uhrin M, Karenchak LM, Sweet RL, Gordon YJ. Evaluation of the polymerase chain reaction test for detecting chlamydial DNA in adult chlamydial conjunctivitis. Ophthalmology 1995; 102: 1061-119.
33. 33 Baselski VS. The role of molecular diagnostics in the clinical microbiology laboratory. Clin Lab Med 1996; 16: 49-60.
34. 34 Bas S, Griffais R, Kvien TK, Glennås A, Melby K, Vischer TL. Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies. Arth Rheum 1995; 38: 1005-13.
35. 35 Cheema MA, Schumacher HR, Hudson AP. RNA-directed molecular hybridization screening: evidence for inapparent chlamydial infection. Amer J Med Sci 1991; 302: 261-8.
36. 36. Holland SM, Hudson AP, Bobo L, Whittum-Hudson JA, Viscidi RP, Quinn TC, Taylor HE. Demonstration of chlamydial RNA and DNA during a culture-negative state. Infect Immun 1992; 60: 2040-7.
37. 37 Malinverni R, Kuo C-C, Campbell LA, Lee A, Grayston JT. Effects of two antibiotic regimens on course and persistence of experimental Chlamydia pneumoniae TWAR pneumonitis. Antimicrob Agents Chemother 1995; 39: 45-9.
38. 38 Workowski KA, Lampe MF, Wong KG, Watts MB, Stamm WE. Long-term eradication of Chlamydia trachomatis genital infection after antimicrobial therapy. J Amer Med Assoc 1993; 270: 2071-5.
39. 39 Thomas BJ, Macleod EJ, Taylor-Robinson D. Evaluation of a commercial polymerase chain reaction assay for Chlamydia trachomatis and suggestions for improving sensitivity. Eur J Clin Microbiol Infect Dis 1995; 14: 719-23.
40. 40 Yang Y-S, Kuo C-C, Chen W-J. Reactivation of Chlamydia trachomatis lung infection in mice by cortisone. Infect Immun 1983; 69: 655-8.
41. 41 Malinverni R, Kuo C-C, Campbell LA, Grayston JT. Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone. J Infect Dis 1995; 172: 593-4.
42. 42 Laitinen K, Laurila AL, Leinonen M, Saikku P. Reactivation of Chlamydia pneumoniae infection in mice by cortisone treatment. Infect Immun 1996; 64: 1488-90.
43. 43 Landers DV, Sung ML, Bottles K, Schachter J. Does addition of anti-inflammatory agents to antimicrobial therapy reduce infertility after murine chlamydial salpingitis? Sex Transm Dis 1993; 20: 121-5.
44. 44 Smith GM, Abbott KH, Wilkinson MJ, Beale AS, Sutherland R. Bactericidal effects of ticarcillin/clavulanic acid against a Legionella pneumophila pneumonia in immunocompromised weanling rats. Antimicrob Agents Chemother 1991; 35: 1423-9.
45. 45 Masson ND, Toseland CDN, Beale AS. Relevance of Chlamydia pneumoniae murine pneumonitis model to evaluation of antimicrobial agents. Antimicrob Agents Chemother 1995; 39: 1959-64.
46. 46 Byrne GI, Grubbs B, Dickey TJ, Schachter J, Williams DM. Interferon in recovery from pneumonia due to Chlamydia trachomatis in the mouse. J Infect Dis 1987; 156: 993-6.
47. 47 Beale AS, Faulds E, Hum SE, Tyler J, Slocombe B. Comparative activities of amoxycillin, amoxycillin/clavulanic acid and tetracycline against Chlamydia trachomatis in cell culture and in an experimental mouse pneumonitis. J Antimicrob Chemother 1991; 27: 627-38.
48. 48 Beatty WL, Morrison RP, Byrne GI. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev 1994; 58: 686-99.
49. 49 Yoshida R, Urade Y, Nakata K, Watanabe Y, Hayaishi O. Specific induction of indoleamine 2,3-dioxygenase by bacterial lipopolysaccharide in the mouse lung. Arch Biochem Biophys 1981; 212: 629-37.
50. 50 Bianchi M, Bertini R, Ghezzi P. Induction of indoleamine dioxygenase by interferon in mice: a study with different recombinant interferons and various cytokines. Biochem Biophys Res Comm 1988; 152: 237-42.
51. 51 Stern JE, Wira CR. Progesterone regulation of secretory component (SC): uterine SC response in organ culture following in vivo hormone treatment. J Steroid Biochem 1988; 30: 1-6.
52. 52 Plata F, Wietzerbin J, Pons FG, Flacoff E, Eisen H. Synergistic protection by specific antibodies and interferon against infection by Trypanosoma cruzi in vitro. Eur J Immunol 1984; 14: 930-5.
53. 53 Beatty WL, Morrison RP, Byrne GI. Immunoelectronmicroscopic quantitation of differential levels of chlamydial proteins in a cell culture model of persistent Chlamydia trachomatis infection. Infect Immun 1994; 62: 4059-62.
54. 54 Tuffrey M, Taylor-Robinson D. Progesterone as a key factor in the development of a mouse model for genital tract infection with Chlamydia trachomatis. Microbiol Lett 1981; 12: 111-5.